Locally Advanced Rectal Adenocarcinoma
13 clinical trials · Condition
◉ Watch Locally Advanced Rectal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer (NCT04751370) | National Cancer Institute (NCI) | 2022-02-08 |
| INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer (NCT04130854) | University of Texas Southwestern Medical Center | 2020-04-24 |
| Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer (NCT03300544) | National Cancer Institute (NCI) | 2019-05-14 |
| Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer (NCT02874885) | M.D. Anderson Cancer Center | 2013-09-05 |
| XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma (NCT00557713) | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials | 2007-02-01 |
Track Locally Advanced Rectal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.